2022 Experts Included:
13th World Bispecific Summit
The ONLY End-to-End Meeting Dedicated to Advancing the Next Generation of Translational Success of Bi- & Multi-Specific Therapeutics
As multispecifics is hailed the fourth wave of drug discovery, with more clinical candidates and commercial success than ever before, the 13th World Bispecific Summit arrives at a pivotal time to deliver the holy grail of precision oncology.
This industry-leading conference is the largest global gathering of bi-, tri- and multispecific drug discovery and development scientists, from molecule design to manufacturing. Benchmark and update your platform and clinical progress; advance mechanistic diversity, reduced toxicity and higher target affinity; and link manufacturability to novel formats of the next generation.
Network with and gather intelligence from over 150 chemistry, discovery, and clinical drug hunters with expertise in protein engineering, clinical pharmacodynamic, prognostic biomarkers, process development and manufacturability.
Be there in person to consolidate, catch up, and realize the potential of multi-specifics in multi-modal disease!
Among Our World-Class Speaker Faculty
Head Biologics Core Technologies
Associate Director, Cell Therapy Clinical Pharmacology, Modeling & Bioinformatics
Deputy Associate Director - Research Office of Tissue & Advanced Therapies
Chief Scientific Officer
Senior Director of T Cell Engagers